Briakinumab (Anti-IL-12) (IL-12a & IL-12b)
Briakinumab (Anti-IL-12) (IL-12a & IL-12b) (A2947-GRP)
Products
Description
Briakinumab (anti-IL-12) (IL-12a & IL-12b) is a human monoclonal antibody directed against the human interleukins 12 (IL-12) and 23 (IL-23), with immunomodulating activity. It has the potential to be used in the treatment of Crohn's disease. MW: 143.86 KD.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | A2947 |
| Target | Interleukins |